Accessibility settings

Published on in Vol 13 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/65590, first published .
Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project

Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project

Data Interoperability in COVID-19 Vaccine Trials: Methodological Approach in the VACCELERATE Project

Journals

  1. Whitney H, Baccile R, Li H, Drukker K, Meyer C, Gruszauskas N, Chen W, Lauderdale D, Napel S, Kahaki S, Sá R, Beesley C, Phalora B, Michael S, Grossman R, Gersing K, Giger M, Wilcox A, Lee A, Graves A, Anzalone A, Manna A, Saha A, Olex A, Zhou A, Williams A, Southerland A, Girvin A, Walden A, Sharathkumar A, Amor B, Bates B, Hendricks B, Patel B, Alexander C, Bramante C, Ward-Caviness C, MadlockBrown C, Suver C, Chute C, Dillon C, Wu C, Schmitt C, Takemoto C, Housman D, Gabriel D, Eichmann D, Mazzotti D, Brown D, Boudreau E, Hill E, Marti E, Pfaff E, French E, Koraishy F, Mariona F, Prior F, Sokos G, Martin G, Lehmann H, Spratt H, Mehta H, Hayanga J, Pincavitch J, Clark J, Harper J, Islam J, Ge J, Gagnier J, Loomba J, Buse J, Mathew J, Rutter J, McMurry J, Guinney J, Starren J, Crowley K, Bradwell K, Walters K, Wilkins K, Gersing K, Cato K, Murray K, Kostka K, Northington L, Pyles L, Cottrell L, Portilla L, Deacy M, Bissell M, Clark M, Emmett M, Palchuk M, Haendel M, Adams M, Temple-O’Connor M, Kurilla M, Morris M, Safdar N, Garbarini N, Sharafeldin N, Sadan O, Francis P, Burgoon P, Payne P, Jawa R, Erwin-Cohen R, Patel R, Moffitt R, Zhu R, Kamaleswaran R, Hurley R, Miller R, Pyarajan S, Michael S, Bozzette S, Mallipattu S, Vedula S, Chapman S, O’Neil S, Setoguchi S, Hong S, Johnson S, Bennett T, Callahan T, Topaloglu U, Gordon V, Subbian V, Kibbe W, Hernandez W, Beasley W, Cooper W, Hillegass W, Zhang X. Demonstration of Interoperability Between MIDRC and N3C: A COVID-19 Severity Prediction Use Case. Journal of Imaging Informatics in Medicine 2025 View
  2. Thomson K, Agbeleye O, Oparah C, Inskip A, Breckons M, Bardgett M, Bevin-Nicholls A, Hancock H, Mossop H, Phillipson J, Teare D, Walmsley Z, Wilson N, Craig D, Wason J. Towards high-quality and timely interim analyses in adaptive trials: a scoping review of best practice and evidence gaps. Trials 2026 View
  3. Tanriover M, Poulimeneas D, Tsopela G, Kopsidas I, Argyropoulos C, Di Marzo R, Valdenmaiier O, Jakobsen S, Valle Simon P, Carcas-Sansuan A, Olesen O, Cornely O, Pana Z, Zaoutis T, Akova M. Barriers and Opportunities to Include Underrepresented Population Groups in Vaccine Trials: Cross-Sectional, Observational, Online Survey Study From the VACCELERATE Research Network. JMIR Public Health and Surveillance 2026;12:e89025 View